Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics.
Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Gustavo H. Vazquez is a Full Professor at the School of Medicine, Queen's University, Director of the CME and staff member of the Mood Disorders Research and Treatment Service, Department of Psychiatry, Providence Care Hospital, Kingston, ON, Canada. He is a member of the Centre for Neuroscience Studies (CNS) at Queen's University (Kingston, Canada), member of the Centre of Neurosicence at Palermo University (Buenos Aires, Argentina) and member of the International Consortium for Psychotic and Bipolar Disorders Research at McLean Hospital, Harvard Medical School (Boston, United States of America).
Inhaltsangabe
1. Ketamine, Clio, and the hippocratic triangled fragments of the history of ketamine 2. Ketamine's potential mechanism of action for rapid antidepressive effects - a focus on neuroplasticity 3. Treatment resistant depression 4. Suicide in psychiatric disorders: rates, risk factors, and therapeutics 5. Overview of ketamine for major depression: efficacy and effectiveness 6. How to implement a ketamine clinic 7. Development of new rapid-action treatments in mood disorders 8. Closing remarks
1. Ketamine, Clio, and the hippocratic triangled fragments of the history of ketamine 2. Ketamine's potential mechanism of action for rapid antidepressive effects - a focus on neuroplasticity 3. Treatment resistant depression 4. Suicide in psychiatric disorders: rates, risk factors, and therapeutics 5. Overview of ketamine for major depression: efficacy and effectiveness 6. How to implement a ketamine clinic 7. Development of new rapid-action treatments in mood disorders 8. Closing remarks